Trial Search Results

Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19

The purpose of this study is to test over time immunity to SARS-CoV-2, a recently identified coronavirus responsible for the 2019 world-wide pneumonia outbreak known as COVID-19. Adults and children diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Institute of Allergy and Infectious Diseases (NIAID)

Stanford Investigator(s):

Intervention(s):

  • Other: There is no intervention

Eligibility


Inclusion Criteria:

   - Adults (18 years and older) and children with confirmed COVID-19 (RT-PCR diagnosis).

   - Adults (18 years and older) and children without COVID-19 for controls (who test
   negative for COVID-19 but may have viral symptoms)

Exclusion Criteria:

   - Patients with special risks attendant to venipuncture will be excluded.

Ages Eligible for Study

2 Years - N/A

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
SNP Center Inquiry
650-521-7237
Recruiting